Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2014
DOI: 10.4236/ojmm.2014.43020
|View full text |Cite
|
Sign up to set email alerts
|

Immunotherapy in Cancer Treatment

Abstract: Various kinds of immunotherapy treatment for cancer are either available to the public or are in the process of clinical trials. Immunotherapy treatments have the potential to treat cancer with significantly less toxicity than chemotherapy and radiation treatments. An emphasis on cellular infusion as a method of either enhancing the immune system by creating an environment for sequestering the host immune system to attack cancer cells or more directly inserting cells to directly attack cancer cells will be pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 144 publications
0
2
0
Order By: Relevance
“…Traditional oncological approaches, including surgery, radiation, and chemotherapy, aim to directly remove or kill cancer cells. In contrast, immunotherapy seeks to enhance the host immune system’s ability to eliminate cancer cells resulting in tumor regression, antitumor immune memory formation, and ultimately in durable responses ( 1 , 2 ). Induction of the host immune system via increases in innate and adaptive immune surveillance of and response against the tumor can provide lasting positive outcomes in cancer patients ( 3 ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Traditional oncological approaches, including surgery, radiation, and chemotherapy, aim to directly remove or kill cancer cells. In contrast, immunotherapy seeks to enhance the host immune system’s ability to eliminate cancer cells resulting in tumor regression, antitumor immune memory formation, and ultimately in durable responses ( 1 , 2 ). Induction of the host immune system via increases in innate and adaptive immune surveillance of and response against the tumor can provide lasting positive outcomes in cancer patients ( 3 ).…”
Section: Introductionmentioning
confidence: 99%
“…The predilection of these viruses to preferentially infect tumor cells while sparing normal surrounding cells allows for an excellent therapeutic ratio. The ability of OVs to cause immune infiltration into tumors bridges the gap to immunotherapy ( 1 , 4 6 ), and immunologic outcomes are being reported from ongoing and completed clinical trials (Table 1 ).…”
Section: Introductionmentioning
confidence: 99%